The present disclosure relates to a graft material including a reinforced layer and to implantable medical devices including such a graft material. The invention also relates to methods of using and manufacturing such graft materials and devices. In one embodiment the implantable medical device is a stent graft.

The present disclosure relates to a graft material including a reinforced layer and to implantable medical devices including such a graft material. The invention also relates to methods of using and manufacturing such graft materials and devices. In one embodiment the implantable medical device is a stent graft.

A medical device to be inserted into a body at depths greater than 5 cm, includes an echogenic coating composition including: (i) a polymer matrix and (ii) an amount of ultrasound-reflective microparticles having a diameter that is at least 10 and at most 250 μm in size, with a defined relationship between the particle size, expressed as D 50, and the surface density. A method for ultrasound detection of a medical device at a scan depth greater than 5 cm includes providing the medical device with the echogenic coating composition. An echogenic assembly includes the medical device having the echogenic coating composition and a convex probe.

An echogenic coating composition on a medical device to be inserted into a body at depths greater than 5 cm includes: (i) a polymer matrix and (ii) an amount of ultrasound-reflective microparticles having a diameter that is at least 10 and at most 250 μm in size, with a defined relationship between the particle size, expressed as D50, and the surface density. A method for ultrasound detection of a medical device at a scan depth greater than 5 cm includes: providing the medical device with the echogenic coating composition and to an echogenic assembly including the medical device and a convex probe.

The present patent application is directed to compositions and shaped structures implantable into mammalian bodies, the compositions and shaped structures having localized bioactive surfaces.

The present patent application is directed to compositions and shaped structures implantable into mammalian bodies, the compositions and shaped structures having localized bioactive surfaces.

The present disclosure is to provide a medical material, medical protective equipment with both low cytotoxicity and high-efficiency antibacterial, antiviral properties and its manufacturing method. The multi-layer copper-based zeolite fiber medical material of the present disclosure includes a four-layer structure, including the outermost layer, the first intermediate layer, the second intermediate layer, and the innermost layer in sequence; the outermost layer and the second intermediate layer are copper-based zeolite fiber layer, the first intermediate layer is a hydrophobic fiber layer, and the innermost layer is a hydrophilic fiber layer; the pore size of the copper-based zeolite fiber layer of the outermost layer is greater than the pore size of the hydrophobic fiber layer of the first intermediate layer; the copper-based zeolite fiber layer contains copper-based zeolite and fiber threads, the fiber threads are formed by twisting fibers; the copper-based zeolite is independently dispersed on the fiber surface.

A composite implant comprising a bioabsorbable matrix material, an outer sheath of a textile comprising filaments; and a plurality of flexible reinforcing rods held together by the outer sheath; each of the flexible reinforcing rods have a plurality of filaments, and the filaments of the textile and the flexible reinforcing rods include a degradable or resorbable glass. Preferably, the filaments are present in the composite implant in an amount of 20 volume percent to 95 volume percent, based on the total volume of the composite implant.

A medical component is provided which includes a first portion formed of a first elastomeric material having at least one taggant embedded or incorporated therein, and a second portion formed of a second elastomeric material. The at least one taggant has a first diffusivity relative to the first elastomeric material and a second diffusivity relative to the second elastomeric material. The second diffusivity is less than the first diffusivity.

A microneedle assembly that is capable of delivering a drug compound (e.g., vaccine) and/or detecting the presence of an analyte is provided. The assembly comprises at least one microneedle extending outwardly from a support. The microneedle includes a polymer composition containing a thermoplastic polymer having a melting temperature of about 250° C. or more. The polymer composition exhibits a melt viscosity of about 100 Pa-s or less and a tensile elongation of about 5% or less.